FDA Elevates Office of Strategic Partnerships and Technology Innovation to Super Office

The CDRH Office of Strategic Partnerships and Technology Innovation (OST) has been elevated to a super office, effective immediately, a designation that the FDA says will allow OST to adapt to and address future public health needs and challenges.
Source: Drug Industry Daily